VCU receives $6.3M+ grant for pediatric cancer research

Cigall Kadoch wins $250,000 Blavatnik National Award

Cigall Kadoch was named the laureate of the Blavatnik National Awards for Young Scientists in the field of life sciences for her work in cancer biology.

September 20, 2024

Vol.50 No.35

In Brief

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

CureSearch for Children’s Cancer will award $2 million in funding to support a phase I clinical trial in 24 children and young adults with recurrent brain tumors.

September 06, 2024

Vol.50 No.33

In Brief

Cheng-Chia Wu joins Fralin Biomedical Research Institute at Virginia Tech Carilion

Cheng-Chia “Fred” Wu, a physician-scientist who treats brain tumors in children, has joined Virginia Tech to bring his expertise in focused ultrasound cancer research to the Fralin Biomedical Research Institute at Virginia Tech Carilion.

August 09, 2024

Vol.50 No.32

Clinical Roundup

Socioeconomic status affects survival of children with cancer

Socioeconomic factors can influence the diagnosis and treatment of children in Texas with malignant solid tumors, increasing the risk of the cancer’s spread and lowering the five-year survival rate, according to researchers at UT Southwestern Medical Center.

July 26, 2024

Vol.50 No.30

Clinical Roundup

Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men

Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, research suggests, which could contribute to higher rates of aggressive prostate cancer in African American men.

July 19, 2024

Vol.50 No.29

Clinical Roundup

Degradation of HER2, EGFR may overcome drug resistance in HER2-positive breast cancers

New research out of VCU Massey Comprehensive Cancer Center—published this month in Drug Resistance Updates—revealed a previously unknown biological process through which breast tumor cells develop resistance to standard treatment. It could open the door for cancer scientists to further target this vulnerability and create more effective therapies for disease.

May 31, 2024

Vol.50 No.22

VCU receives $6.3M+ grant for pediatric cancer research

YOU MAY BE INTERESTED IN

Cigall Kadoch wins $250,000 Blavatnik National Award

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

Cheng-Chia Wu joins Fralin Biomedical Research Institute at Virginia Tech Carilion

Socioeconomic status affects survival of children with cancer

Living in disadvantaged neighborhoods influences stress-related genes, which may contribute to aggressive prostate cancer in African American men

Degradation of HER2, EGFR may overcome drug resistance in HER2-positive breast cancers

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login